| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24201-207-01 | 24201-207 | HUMAN PRESCRIPTION DRUG | Icatibant | icatibant | INJECTION, SOLUTION | SUBCUTANEOUS | 20200309 | N/A | ANDA | ANDA211021 | Hikma Pharmaceuticals USA Inc. | ICATIBANT ACETATE | 30 mg/3mL | 1 SYRINGE, GLASS in 1 CARTON (24201-207-01) / 3 mL in 1 SYRINGE, GLASS |
| 24201-207-03 | 24201-207 | HUMAN PRESCRIPTION DRUG | Icatibant | icatibant | INJECTION, SOLUTION | SUBCUTANEOUS | 20200309 | N/A | ANDA | ANDA211021 | Hikma Pharmaceuticals USA Inc. | ICATIBANT ACETATE | 30 mg/3mL | 3 CARTON in 1 CARTON (24201-207-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS |